Refining the Impact of TCF7L2 Gene Variants on Type 2 Diabetes and Adaptive Evolution.

Agnar Helgason,Snæbjörn Pálsson,Gudmar Thorleifsson,Struan F A Grant,Valur Emilsson,Steinunn Gunnarsdottir,Adebowale Adeyemo,Yuanxiu Chen,Guanjie Chen,Inga Reynisdottir,Rafn Benediktsson,Anke Hinney,Torben Hansen,Gitte Andersen,Knut Borch-Johnsen,Torben Jorgensen,Helmut Schäfer,Mezbah Faruque,Ayo Doumatey,Jie Zhou,Robert L Wilensky,Muredach P Reilly,Daniel J Rader,Yu Bagger,Claus Christiansen,Gunnar Sigurdsson,Johannes Hebebrand,Oluf Pedersen,Unnur Thorsteinsdottir,Jeffrey R Gulcher,Augustine Kong,Charles Rotimi,Kári Stefánsson

DOI: https://doi.org/10.1038/ng1960

IF: 30.8

2007-01-01

Nature Genetics

Abstract:We recently described an association between risk of type 2diabetes and variants in the transcription factor 7-like 2 gene ( TCF7L2 ; formerly TCF4 ), with a population attributable risk (PAR) of 17%–28% in three populations of European ancestry 1 . Here, we refine the definition of the TCF7L2 type 2diabetes risk variant, HapB T2D , to the ancestral T allele of a SNP, rs7903146, through replication in West African and Danish type 2 diabetes case-control studies and an expanded Icelandic study. We also identify another variant of the same gene, HapA, that shows evidence of positive selection in East Asian, European and West African populations. Notably, HapA shows a suggestive association with body mass index and altered concentrations of the hunger-satiety hormones ghrelin and leptin in males, indicating that the selective advantage of HapA may have been mediated through effects on energy metabolism.